Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cutts

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Cancers|March 11, 2023
Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix CancerSusan Lalondrelle, Jen Lee, Rosalind J Cutts, et al.
Frontiers in Oncology|May 5, 2020
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)Jen Y Lee, Rosalind J Cutts, Ingrid White, et al.
Iscience|June 18, 2021
Time-restricted feeding rescues high-fat-diet-induced hippocampal impairmentJennifer A Davis, Jodi R Paul, Stefani D Yates, et al.
Cancers|May 13, 2023
Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility StudyStacey J Bryan, Jen Lee, Richard Gunu, et al.
Journal of the National Cancer Institute|September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast CancerBen O'Leary, Rosalind J Cutts, Xin Huang, et al.
British Journal of Cancer|August 16, 2017
Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinomaJen Y Lee, Isaac Garcia-Murillas, Rosalind J Cutts, et al.
Cancer Discovery|September 13, 2018
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 TrialBen O'Leary, Rosalind J Cutts, Yuan Liu, et al.
Plos One|September 29, 2015
Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR ApproachAlexandra Pender, Isaac Garcia-Murillas, Sareena Rana, et al.
Genes and Immunity|December 4, 2015
A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean childrenL Manning, J Cutts, D I Stanisic, et al.
Science Translational Medicine|August 28, 2015
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancerIsaac Garcia-Murillas, Gaia Schiavon, Britta Weigelt, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Cancers|March 11, 2023
Predicting Response to Radical Chemoradiotherapy with Circulating HPV DNA (cHPV-DNA) in Locally Advanced Uterine Cervix CancerSusan Lalondrelle, Jen Lee, Rosalind J Cutts, et al.
Frontiers in Oncology|May 5, 2020
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC)Jen Y Lee, Rosalind J Cutts, Ingrid White, et al.
Iscience|June 18, 2021
Time-restricted feeding rescues high-fat-diet-induced hippocampal impairmentJennifer A Davis, Jodi R Paul, Stefani D Yates, et al.
Cancers|May 13, 2023
Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility StudyStacey J Bryan, Jen Lee, Richard Gunu, et al.
Journal of the National Cancer Institute|September 17, 2020
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast CancerBen O'Leary, Rosalind J Cutts, Xin Huang, et al.
British Journal of Cancer|August 16, 2017
Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinomaJen Y Lee, Isaac Garcia-Murillas, Rosalind J Cutts, et al.
Cancer Discovery|September 13, 2018
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 TrialBen O'Leary, Rosalind J Cutts, Yuan Liu, et al.
Plos One|September 29, 2015
Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR ApproachAlexandra Pender, Isaac Garcia-Murillas, Sareena Rana, et al.
Genes and Immunity|December 4, 2015
A Toll-like receptor-1 variant and its characteristic cellular phenotype is associated with severe malaria in Papua New Guinean childrenL Manning, J Cutts, D I Stanisic, et al.
Science Translational Medicine|August 28, 2015
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancerIsaac Garcia-Murillas, Gaia Schiavon, Britta Weigelt, et al.
Pageof 5